These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 23169359

  • 1. Maintaining residual renal function in patients on haemodialysis: 5-year experience using a progressively increasing dialysis regimen.
    Fernández-Lucas M, Teruel-Briones JL, Gomis-Couto A, Villacorta-Pérez J, Quereda-Rodríguez-Navarro C.
    Nefrologia; 2012; 32(6):767-76. PubMed ID: 23169359
    [Abstract] [Full Text] [Related]

  • 2. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.
    Teruel-Briones JL, Fernández-Lucas M, Rivera-Gorrin M, Ruiz-Roso G, Díaz-Domínguez M, Rodríguez-Mendiola N, Quereda-Rodríguez-Navarro C.
    Nefrologia; 2013; 33(5):640-9. PubMed ID: 24089155
    [Abstract] [Full Text] [Related]

  • 3. Impact of combination therapy with peritoneal dialysis and hemodialysis on peritoneal function.
    Moriishi M, Kawanishi H, Tsuchiya S.
    Adv Perit Dial; 2010; 26():67-70. PubMed ID: 21348383
    [Abstract] [Full Text] [Related]

  • 4. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose.
    Vilar E, Wellsted D, Chandna SM, Greenwood RN, Farrington K.
    Nephrol Dial Transplant; 2009 Aug; 24(8):2502-10. PubMed ID: 19240122
    [Abstract] [Full Text] [Related]

  • 7. Peritoneal dialysis and kidney transplant. A two-way ticket in an integrated renal replacement therapy model.
    Portolés J, Moreno F, López-Sánchez P, Mancha J, Gómez M, Corchete E, Del Peso G, Bajo MA, Llópez-Carratalá R, Fernández-Perpén A, Grupo Centro Diálisis Peritoneal-GCDP, REDinREN.
    Nefrologia; 2011 Aug; 31(4):441-8. PubMed ID: 21738247
    [Abstract] [Full Text] [Related]

  • 8. Estimation of residual glomerular filtration rate and renal Kt/Vurea from creatinine clearance in end-stage renal disease patients. The Netherlands Cooperative Study on the Adequacy of Dialysis.
    Korevaar JC, Jansen MA, Dekker FW, Boeschoten EW, Krediet RT.
    Adv Perit Dial; 1999 Aug; 15():132-7. PubMed ID: 10682088
    [Abstract] [Full Text] [Related]

  • 9. Is there impact of mortality prior hemodialysis therapy in peritoneal dialysis patients?
    Koc Y, Unsal A, Basturk T, Sakaci T, Ahbap-Dal E, Sinangil-Arar A, Kose-Budak S, Kayabasi H.
    Nefrologia; 2012 May 14; 32(3):335-42. PubMed ID: 22508142
    [Abstract] [Full Text] [Related]

  • 10. Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma.
    Martín-Reyes G, Toledo-Rojas R, Torres-de Rueda Á, Sola-Moyano E, Blanca-Martos L, Fuentes-Sánchez L, Martínez-Esteban MD, Díez-de los Ríos MJ, Bailén-García A, González-Molina M, García-González I.
    Nefrologia; 2012 May 14; 32(1):35-43. PubMed ID: 22294003
    [Abstract] [Full Text] [Related]

  • 11. The variable target model: a paradigm shift in the incremental haemodialysis prescription.
    Casino FG, Basile C.
    Nephrol Dial Transplant; 2017 Jan 01; 32(1):182-190. PubMed ID: 27742823
    [Abstract] [Full Text] [Related]

  • 12. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep 01; 423():1-336. PubMed ID: 12616288
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effectiveness of furosemide in patients on peritoneal dialysis.
    Flinn A, Ledger S, Blake P.
    CANNT J; 2006 Sep 01; 16(3):40-4. PubMed ID: 17061696
    [Abstract] [Full Text] [Related]

  • 15. [Prognostic significance of programmed dialysis in patients who initiate renal substitutive treatment. Multicenter study in Spain].
    Górriz JL, Sancho A, Pallardó LM, Amoedo ML, Martín M, Sanz P, Barril G, Selgas R, Salgueira M, Palma A, de la Torre M, Ferreras I.
    Nefrologia; 2002 Sep 01; 22(1):49-59. PubMed ID: 11987685
    [Abstract] [Full Text] [Related]

  • 16. Dialysis dose and frequency.
    Locatelli F, Buoncristiani U, Canaud B, Köhler H, Petitclerc T, Zucchelli P.
    Nephrol Dial Transplant; 2005 Feb 01; 20(2):285-96. PubMed ID: 15598667
    [Abstract] [Full Text] [Related]

  • 17. Could incremental haemodialysis be a new standard of care? A suggestion from a long-term observational study.
    Casino FG, Lopez T, Santarsia G, Mostacci SD, Sabato A, Di Carlo M, Procida C, Saracino A, Deira J, Basile C.
    G Ital Nefrol; 2022 Jun 20; 39(3):. PubMed ID: 35819039
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1997 Apr 20; 450():1-321. PubMed ID: 12594525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.